Chloroquine blocks the autophagic process in cisplatin-resistant osteosarcoma cells by regulating the expression of p62/SQSTM1

International Journal of Molecular Medicine

Volumn 32, Issue 2, 2013, Pages 448-456

  Shen, Chengchun ^a   Wang, Wenzhe ^b   Tao, Lijiang ^a   Liu, Bing ^a   Yang, Zhengming ^a   Tao, Huimin ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Autophagy; Chloroquine; Cisplatin; Osteosarcoma; P62 sequestosome 1

Indexed keywords

BINDING PROTEIN; CHLOROQUINE; CISPLATIN; GREEN FLUORESCENT PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 1; PROTEIN P62; SEQUESTOSOME 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CANCER RESISTANCE; CELL COUNT; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; EXPRESSION VECTOR; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIGHT CHAIN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AUTOPHAGY; CELL DEATH; CELL LINE, TUMOR; CHLOROQUINE; CISPLATIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OSTEOSARCOMA; PHAGOSOMES;

EID: 84879327956     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1399     Document Type: Article

References (26)

1. Bacci G, Ferrari S, Bertoni F, et al: Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: An updated report. J Clin Oncol 18: 4016-4027, 2000. (Pubitemid 32038393)
2. Brozovic A and Osmak M: Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance. Cancer Lett 251: 1-16, 2007. (Pubitemid 46589761)
3. Gorlick R, Anderson P, Andrulis I, et al: Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: Meeting summary. Clin Cancer Res 9: 5442-5453, 2003. (Pubitemid 37499462)
4. Reggiori F and Klionsky DJ: Autophagy in the eukaryotic cell. Eukaryot Cell 1: 11-21, 2002. (Pubitemid 36562345)
5. Codogno P and Meijer AJ: Autophagy and signaling: Their role in cell survival and cell death. Cell Death Differ 12 (Suppl 2): 1509-1518, 2005. (Pubitemid 41553987)
6. Levine B and Yuan J: Autophagy in cell death: An innocent convict? J Clin Invest 115: 2679-2688, 2005. (Pubitemid 41434392)
7. Kondo Y, Kanzawa T, Sawaya R and Kondo S: The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5: 726-734, 2005. (Pubitemid 41486365)
8. Krysko DV and Vandenabeele P: From regulation of dying cell engulfment to development of anti-cancer therapy. Cell Death Differ 15: 29-38, 2008. (Pubitemid 350286170)
9. Degenhardt K, Mathew R, Beaudoin B, et al: Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10: 51-64, 2006.
10. Amaravadi RK, Yu D, Lum JJ, et al: Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 117: 326-336, 2007. (Pubitemid 46203961)
11. Rosenfeldt MT and Ryan KM: The role of autophagy in tumour development and cancer therapy. Expert Rev Mol Med 11: E36, 2009.
12. Jin S and White E: Tumor suppression by autophagy through the management of metabolic stress. Autophagy 4: 563-566, 2008.
13. O'Donovan TR, O'Sullivan GC and McKenna SL: Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics. Autophagy 7: 509-524, 2011.
14. Sun WL, Chen J, Wang YP and Zheng H: Autophagy protects breast cancer cells from epirubicin-induced apoptosis and facilitates epirubicin-resistance development. Autophagy 7: 1035-1044, 2011.
15. Seibenhener ML, Geetha T and Wooten MW: Sequestosome 1/p62-more than just a scaffold. FEBS Lett 581: 175-179, 2007. (Pubitemid 46096472)
16. Komatsu M, Kurokawa H, Waguri S, et al: The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 12: 213-223, 2010.
17. Bjorkoy G, Lamark T and Johansen T: P62/SQSTM1: A missing link between protein aggregates and the autophagy machinery. Autophagy 2: 138-139, 2006.
18. Kirkin V, McEwan DG, Novak I and Dikic I: A role for ubiquitin in selective autophagy. Mol Cell 34: 259-269, 2009.
19. Shvets E, Fass E, Scherz-Shouval R and Elazar Z: The N-terminus and Phe52 residue of LC3 recruit p62/SQSTM1 into autophagosomes. J Cell Sci 121: 2685-2695, 2008.
20. Linares JF, Amanchy R, Greis K, Diaz-Meco MT and Moscat J: Phosphorylation of p62 by cdk1 controls the timely transit of cells through mitosis and tumor cell proliferation. Mol Cell Biol 31: 105-117, 2011.
21. Kabeya Y, Mizushima N, Ueno T, et al: LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19: 5720-5728, 2000.
22. Bjorkoy G, Lamark T, Brech A, et al: P62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 171: 603-614, 2005. (Pubitemid 41668720)
23. Solomon VR and Lee H: Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapies. Eur J Pharmacol 625: 220-233, 2009.
24. Tanida I, Minematsu-Ikeguchi N, Ueno T and Kominami E: Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy 1: 84-91, 2005.
25. Kaini RR and Hu CA: Synergistic killing effect of chloroquine and androgen deprivation in LNCaP cells. Biochem Biophys Res Commun 425: 150-156, 2012.
26. Sasaki K, Tsuno NH, Sunami E, et al: Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells. BMC Cancer 10: 370, 2010.